
Acting FDA commissioner calls for independent investigation into approval of Alzheimer's drug
CNN
US Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer's disease drug Aduhelm.
In a letter posted on Twitter, Woodcock said an independent review and assessment should consider interactions between Biogen, the company that makes Aduhelm, and the FDA during the process that led to the June approval of the drug.More Related News

A number of Jeffrey Epstein survivors voiced their concern in a private meeting with female Democratic lawmakers earlier this week about the intermittent disclosure of Epstein-related documents and photos by Democrats on the House Oversight Committee, sharing that the selective publication of materials was distressing, four sources familiar with the call told CNN.












